Related Experiment Videos
Hepatitis B vaccination in children with juvenile idiopathic arthritis
O Kasapçopur1, F Cullu, A Kamburoğlu-Goksel
1Department of Pediatrics, Cerrahpaa Medical Faculty, Istanbul University, Istanbul, Turkey. ozgurcopur@e-kolay.net
Insights
Children with juvenile idiopathic arthritis (JIA) respond well to hepatitis B vaccination, even with immunosuppressive treatment. A 0, 1, and 6-month schedule may offer a better response than a 0, 1, and 3-month schedule.
Area of Science:
- Immunology
- Pediatrics
- Rheumatology
Background:
- Children with juvenile idiopathic arthritis (JIA) require careful management, including vaccination.
- Assessing immune response to vaccines in JIA patients is crucial for effective prophylaxis.
Purpose of the Study:
- To evaluate the hepatitis B vaccine response in children with JIA.
- To compare two different hepatitis B vaccination schedules (0, 1, 3 months vs. 0, 1, 6 months).
- To determine if immunosuppressive therapy affects vaccine responsiveness.
Main Methods:
- 39 children with JIA in remission and 41 healthy controls were enrolled.
- Two vaccination schedules were used: 0, 1, 3 months (Group I) and 0, 1, 6 months (Group II).
- Responsiveness was defined as an anti-hepatitis B antibody titre > 10 mIU/ml.
Main Results:
- All but one JIA patient showed an antibody response; no JIA patients experienced disease flares post-vaccination.
- Antibody levels in JIA patients were lower than in healthy controls.
- The 0, 1, 6-month schedule showed a trend towards a greater response in JIA patients (p<0.07), with no difference in controls.
- Methotrexate or prednisolone treatment did not impact vaccine responsiveness.
Conclusions:
- Children with JIA demonstrate an adequate response to hepatitis B vaccination.
- Immunosuppressive treatments did not impede vaccine response in this cohort.
- A 0, 1, 6-month vaccination schedule appears more beneficial for JIA patients than a 0, 1, 3-month schedule.
Objectives:
To evaluate the responsiveness of children with juvenile idiopathic arthritis (JIA) to hepatitis B vaccination and to determine the most useful vaccination schedule.
Methods:
39 children with JIA were enrolled in the study; all were in remission and negative to serological testing for hepatitis B surface antigen (HbsAg). The control group consisted of 41 healthy children. There were two different vaccination schedules: group I was vaccinated at 0, 1, and 3 months; group II was vaccinated at 0, 1, and 6 months. Positive responsiveness to the vaccine was defined as an anti-hepatitis B antibody titre above 10 mIU/ml.
Results:
All the children except one with systemic JIA developed an antibody response. None of the JIA patients experienced a flare up or clinical deterioration related to the vaccination. The antibody levels in children with JIA were significantly lower than in the healthy controls. Comparison of the antibody levels between the two vaccination schedules showed no statistical difference in the controls; in the JIA subjects the group II schedule resulted in a trend to a greater response than the group I schedule (p<0.07). Vaccine responsiveness was not influenced by either methotrexate or prednisolone treatment.
Conclusions:
Children with JIA had an adequate response to hepatitis B vaccination and the response was not affected by immunosuppressive treatment. A vaccination schedule at 0, 1, and 6 months seems to be preferable to 0, 1, and 3 months.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Chickenpox
Vaccinations
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Arboviral Encephalitis